Bacopa Monnieri (20% Bacosides)

Bacosides (the active compounds in Bacopa) enhance the activity of kinase proteins involved in neuronal signaling, support the repair of damaged neurons, and increase the synthesis of acetylcholine — the neurotransmitter critical for memory formation and learning. Bacopa also reduces beta-amyloid accumulation and has significant antioxidant activity in brain tissue.

The primary memory-enhancement ingredient in CogHealth™. Unlike stimulant-based nootropics that provide short-term cognitive enhancement through dopamine/norepinephrine release, Bacopa produces structural improvements in neuronal connectivity — the effects build over time and persist after discontinuation.

One of the most studied nootropic herbs with multiple RCTs. A 2001 study (Roodenrys et al.) showed significant improvement in verbal learning rate and memory consolidation. A 2012 meta-analysis confirmed consistent memory benefits across studies. Standardized to 20% bacosides is the clinically validated specification.

300–450mg daily. Bacopa is fat-soluble — always take with food. Effects on memory consolidation typically require 8–12 weeks of consistent use. Unlike stimulants, the benefits are cumulative and structural.